Navigation Links
Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry

SANTA CLARA, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign, a proprietary method of straightening teeth without wires or brackets, today announced approval of its Continuing Education Program by the Academy of General Dentistry's (AGD) Program Approval for Continuing Education (PACE) Committee.

PACE is an evaluation of the educational processes used in designing, planning and implementing continuing education. It was created to assist the dental profession in identifying and participating in quality continuing dental education.

"We are pleased that the AGD has approved our program, and in so doing, has recognized our dedication to continuing education," said Dr. Lou Shuman, vice president of strategic relations for Align. "Our acceptance in the dental community has been a direct result of the commitment we have to educating providers on the applicability of the Invisalign technique in their practice, and the general benefits it provides to their patients."

Align's Clinical Education department is working to provide a "True Continuum of Learning." The team's goal is to create diverse educational resources for Invisalign providers -- from the novice to the most advanced practitioner -- in a wide variety of delivery formats, thereby accommodating each customer's unique learning preferences.

To be considered for PACE, organizations that are national or international in scope, providing programs in more than one state or province or drawing a significant amount of participants from more than one state or province, submit applications that are then reviewed by a nine-member committee. Program providers must adhere to over one dozen published standards and criteria in different areas to receive and maintain approval status.

"Align has an incredible team that is dedicated to creating and managing the significant amount of education they provide each year," said AGD President Vincent C. Mayher, DMD, MAGD. "The PACE approval is recognition of Align's professional commitment to continuing education, both now and in the future."

Program providers approved through the AGD are approved to offer credit hours that can be applied towards the AGD's Fellowship (FAGD) and Mastership (MAGD) award programs. Currently, just under 500 program providers have received national approval by the AGD's PACE Committee.

The AGD is a professional association of more than 33,000 general dentists dedicated to staying up-to-date in the profession through continuing education. Founded in 1952, the AGD has grown to become the world's second largest dental association, which is the only association that exclusively represents the needs and interests of general dentists. A general dentist is the primary care provider for patients of all ages and is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs. Visit

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

SOURCE Align Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. A better test than cytology for Urinary Malignancy
2. Blood test developed for malignant hyperthermia
3. Malignant Mesothelioma – A New Genetic Revelatio
4. Malignant Mesothelioma – A New Genetic Revelation
5. Malignant virus in polio vaccine combined to Cancer
6. Indian Researcher Discovers Reason For Malignancy of Skin Cancer
7. Experimental Therapy Effective Against Malignant Melanoma in Horses
8. Seattle, a hub for malignant melanoma? Time To Get Sunwise!
9. Protein Involved In Embryo Formation Found In Malignant Cells
10. When Her Lot is maligned by HER-2, Staying Abreast is Imperative
11. Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: